Duane Mitchell

13PUBLICATIONS
57CO-AUTHORS
Molecular targetsGene and molecular therapyStylistics and textual analysisCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 24, 2026
Improving Immune Checkpoint Blockade Efficacy in Melanoma Brain Metastases through Myddosomal inhibition with Emavusertib.

|Jun 12, 2025
A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial.

Eric M Thompson, David M Ashley, Katayoun Ayasoufi

|Aug 19, 2024
Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma.

Changlin Yang, Vrunda Trivedi, Kyle Dyson

|Jul 12, 2024
Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade.

Christina A von Roemeling, Jeet A Patel, Savannah L Carpenter

|Jan 24, 2024
mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors.

Vrunda Trivedi, Changlin Yang, Kelena Klippel

|Nov 28, 2023
CXCL9 recombinant adeno-associated virus (AAV) virotherapy sensitizes glioblastoma (GBM) to anti-PD-1 immune checkpoint blockade.

Christina von Roemeling, Oleg Yegorov, Changlin Yang

Pageof 3

Frequent Collaborators

3 joint publications

Bently P Doonan

3 joint publications

Christina A Von Roemeling

3 joint publications

Adam J Grippin

2 joint publications

Tyler J Wildes